RECRUITING

Study to Evaluate the Reliability, Validity and Safety of Subjective Mobile Refraction

Talk to us

Conditions

Refractive ErrorsMyopiaMobile Applications

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study evaluates the reliability, validity and safety of a self administered, subjective refraction test via a mobile medical app (GoEyes) as compared to standard of care subjective manifest refraction performed by a health care provider, in subjects who have no known ocular disease or condition other than refractive error.

Official Title

A Prospective, Multicenter, Open Label Study to Evaluate the Reliability, Validity and Safety of Subjective Mobile Refraction Assessed by GoEyes

Quick Facts

Study Start:2021-09-15
Study Completion:2023-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05049070

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 39 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Males or females aged 18-39 years who currently wear glasses and/or soft contact lenses to correct refractive error
  2. 2. Normal color vision
  3. 3. Able to use both hands at the same time and to hear, understand and verbally respond to audio instructions
  4. 4. Have single vision lenses only
  5. 5. Able to provide informed consent -
  1. 1. Have any ongoing disease or ocular condition other than refractive error
  2. 2. Have a history of permanent vison loss
  3. 3. Have a neurological condition affecting vision
  4. 4. Have worn glasses since age 6 or younger
  5. 5. Have a prism in their prescription
  6. 6. Use Rigid gas permeable lenses or OrthoK lenses
  7. 7. Have had laser refractive surgery or any other eye surgery
  8. 8. Use prescription eye drops -

Contacts and Locations

Study Contact

Karen Howse
CONTACT
khowse@luna.io

Study Locations (Sites)

Matrix Clinical Research
Beverly Hills, California, 90210
United States
North Bay Eye Associates
Petaluma, California, 94954
United States
Empire Clinical Research
Pomona, California, 91767
United States
Segal Drug Trials
Delray Beach, Florida, 33484
United States
Butchertown Clinical Trials
Louisville, Kentucky, 40206
United States
Tauber Eye Center
Kansas City, Missouri, 64111
United States
IMA Research
Las Vegas, Nevada, 89102
United States
Core, Inc Vita Eye Clinic
Shelby, North Carolina, 28150
United States
Athens Eye Care
Athens, Ohio, 45701
United States
Optimed Research
Marysville, Ohio, 43040
United States
Total Eye Care
Memphis, Tennessee, 38119
United States
Wagner Macula & Retina
Norfolk, Virginia, 23454
United States

Collaborators and Investigators

Sponsor: 1800 Contacts, Inc.

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-09-15
Study Completion Date2023-06

Study Record Updates

Study Start Date2021-09-15
Study Completion Date2023-06

Terms related to this study

Keywords Provided by Researchers

  • Refractive Errors
  • Myopia
  • Mobile Applications

Additional Relevant MeSH Terms

  • Refractive Errors